Evidence map›Paper›PMID 41919009›Full record

ArticleInfection and drug resistance2026

Invasive Pulmonary Aspergillosis in an Immunocompetent Patient Following Occupational Exposure to Iron Oxide Dust: A Long-Term Follow-Up Case Report.

Chenwei Zhou, Leru Chao, Cui Guo, Yanjuan Zhou

Abstract readCase Reports
In one paragraph

Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chenwei ZhouDepartment of Respiratory and Critical Care Medicine, Wujin Hospital Affiliated with Jiangsu University, Changzhou, People's Republic of China.
Leru ChaoDepartment of Pathology, Wujin Hospital Affiliated with Jiangsu University, Changzhou, People's Republic of China.
Cui GuoDepartment of Clinical Laboratory, Wujin Hospital Affiliated with Jiangsu University, Changzhou, People's Republic of China.
Yanjuan ZhouDepartment of Respiratory and Critical Care Medicine, Wujin Hospital Affiliated with Jiangsu University, Changzhou, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Invasive pulmonary aspergillosis (IPA) is a life-threatening fungal infection that predominantly occurs in immunocompromised hosts. However, IPA may also develop in immunocompetent individuals following substantial environmental or occupational exposure, though such cases are rare and often underrecognized. To our knowledge, there are limited reports of IPA associated with iron oxide dust exposure in otherwise healthy individuals, and long-term follow-up data are scarce. Case Presentation: The patient was a 59-year-old male with no history of immunosuppression, who presented with cough, fever, and chest pain one week after heavy occupational inhalation of iron oxide dust. Initially misdiagnosed with bacterial pneumonia, he showed no improvement after empirical antibiotic therapy. Further investigation revealed purulent secretions on bronchoscopy; microbiological culture of sputum and bronchoalveolar lavage fluid grew Results: The patient's symptoms improved significantly after antifungal therapy. A follow-up chest CT at 10 years showed complete resolution of lung lesions without residual fibrosis or structural damage. Conclusion: This case highlights that IPA should be considered in immunocompetent patients with significant occupational or environmental exposures, even in the absence of classic risk factors. Early diagnosis through combined microbiological, serological, and histopathological evaluation is crucial. Long-term follow-up demonstrates that favorable outcomes can be achieved with appropriate antifungal therapy and patient adherence.

Indexed as

immunocompetentinvasive pulmonary aspergillosisiron oxide dustlong-term follow-upoccupational exposure

Identifiers

PMID41919009
PMCPMC13034778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.